We report 25 env gp160 sequences from patients in three geographically distinct districts of Thailand, i.e., Lampang in the north, Trang in the south and Rayong in the east. One of these is a CRF01_AE/subtype B recombinant and the other 24 sequences are purely CRF01_AE. Very little interpopulation diversity was observed between the sequences from the three different geographic regions and from those previously reported by our laboratory from central Thailand. Potential N-linked glycosylation sites (PNLGs) were reasonably conserved among the 25 sequences: we found 15 highly conserved PNLGs on gp120 and 4 almost fully conserved PNLGs on gp41. Analysis of coreceptor tropism revealed that six of the isolates were dual tropic and the others were R5 tropic. We also examined a rare seven amino acid deletion found in one isolate at position 847-853 on gp41. These results may enhance our understanding of HIV-1 currently circulating in Thailand.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1089/aid.2009.0213 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Inducible cell lines producing replication-defective human immunodeficiency virus particles containing envelope glycoproteins stabilized in a pretriggered conformation.
J Virol
December 2024
Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
During the process by which human immunodeficiency virus (HIV-1) enters cells, the envelope glycoprotein (Env) trimer on the virion surface engages host cell receptors. Binding to the receptor CD4 induces Env to undergo transitions from a pretriggered, "closed" (State-1) conformation to more "open" (State 2/3) conformations. Most broadly neutralizing antibodies (bNAbs), which are difficult to elicit, recognize the pretriggered (State-1) conformation.
View Article and Find Full Text PDFSignal peptide exchange alters HIV-1 envelope antigenicity and immunogenicity.
Front Immunol
October 2024
Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
Article Synopsis
- The study focuses on the HIV-1 envelope (Env) protein, crucial for developing effective vaccines, and explores how the signal peptide (SP) affects its antigenicity (ability to trigger immune response) and immunogenicity (ability to induce an immune response).
- Researchers compared the Env proteins from two different HIV-1 isolates, assessing their natural forms and chimeras with swapped SPs, using various methods to evaluate their antigenicity and responses in mice.
- Results showed that swapping SPs influenced the antibodies' binding, with some chimeras showing improved immunogenicity, while the inclusion of DNA vaccines reduced the effectiveness of the wild-type proteins in generating a strong immune response.
Comparison of the immunogenicity of mRNA-encoded and protein HIV-1 Env-ferritin nanoparticle designs.
J Virol
September 2024
Department of Integrative Immunobiology, Duke University School of Medicine, Durham, North Carolina, USA.
Nucleoside-modified mRNA technology has revolutionized vaccine development with the success of mRNA COVID-19 vaccines. We used modified mRNA technology for the design of envelopes (Env) to induce HIV-1 broadly neutralizing antibodies (bnAbs). However, unlike SARS-CoV-2 neutralizing antibodies that are readily made, HIV-1 bnAb induction is disfavored by the immune system because of the rarity of bnAb B cell precursors and the cross-reactivity of bnAbs targeting certain Env epitopes with host molecules, thus requiring optimized immunogen design.
View Article and Find Full Text PDFmRNA lipid nanoparticles expressing cell-surface cleavage independent HIV Env trimers elicit autologous tier-2 neutralizing antibodies.
Front Immunol
August 2024
Wyatt Lab, Department of Immunology and Microbiology, Scripps Research, La Jolla, CA, United States.
Article Synopsis
- - The HIV-1 envelope glycoprotein (Env) is crucial for the virus's ability to infect cells, requiring a specific cleavage process for its subunits to function in viral entry; a new method aims to enhance immunization strategies against HIV by genetically expressing a stable Env trimer on cell surfaces.
- - Researchers developed a 'native flexibly linked' (NFL) construct to simplify the expression of these HIV Env trimers without needing cleavage, ensuring they retain the right structure (native-like conformation) and can effectively stimulate the immune response.
- - The study shows that immunizing rabbits with mRNA lipid nanoparticles containing these membrane-bound stabilized Env trimers elicited strong neutralizing antibody responses, indicating potential for this genetic
Stoichiometry for entry and binding properties of the Env protein of R5 T cell-tropic HIV-1 and its evolutionary variant of macrophage-tropic HIV-1.
mBio
April 2024
Department of Biochemistry and Biophysics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Unlabelled: Human immunodeficiency virus type 1 typically requires a high density of CD4 for efficient entry as a mechanism to target CD4+ T cells (T-tropic), with CCR5 being used most often as the coreceptor. When target T cells are limiting, the virus can evolve to infect cells with a low density of CD4 such as macrophages (M-tropic). The entry phenotype is known to be encoded in the viral Env protein on the surface of the virus particle.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!